Street Talk: Summer No Picnic for Investors - At a time when liquidity is difficult to come by, biopharmaceutical firms will find it difficult to find the capital they need to keep going - BioPharm

ADVERTISEMENT

Street Talk: Summer No Picnic for Investors
At a time when liquidity is difficult to come by, biopharmaceutical firms will find it difficult to find the capital they need to keep going


BioPharm International
Volume 21, Issue 9

IT EXPLAINS A LOT

What to do? Sitting this one out and putting your money into treasuries seems like good common sense. And know that this crisis, too, shall pass. Capital markets have a way of dealing with excess, like we saw with the dotcoms in 1999 and 2000, and with the subprime credit markets today. The market tends to square things away pretty efficiently, even though a lot of people get hurt.

The name of the game is not to be one of those people.

Celebrity author and business/finance commentator for CNN and Fox News, Brian O'Connell has written for The Wall Street Journal and Newsweek, Doylestown, PA, 267.880.3144,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here